Skip to Main
Teon targets metabolic signaling pathways to restore antitumor immunity and suppress cancer cell proliferation
Teon targets metabolic signaling pathways to restore antitumor immunity and suppress cancer cell proliferation

Experienced Executive Team:

Lina Yao, MD, PhD

Acting CEO & CSO

Jim Liu, PhD

VP, Chemistry

Ken Horne

President & COO

Elfatih Elzein, PhD

VP, Chemistry & Early Development

Robert Sikorski, MD, PhD

CMO

Peter Fan, PhD

VP, Biology

Sami Karaborni, PhD

Head of Drug Development

Veronique Lauriault, PhD, DABT

Head of Toxicology

Steve Smith

Head of DMPK